Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002671690 | SCV002997890 | uncertain significance | DOCK2 deficiency | 2022-02-05 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs773407433, gnomAD 0.0009%). This sequence change falls in intron 39 of the DOCK2 gene. It does not directly change the encoded amino acid sequence of the DOCK2 protein. It affects a nucleotide within the consensus splice site. This variant has not been reported in the literature in individuals affected with DOCK2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. |